The Havrix vaccine meets WHO requirements for inactivated vaccines for the prevention of hepatitis A.
The Havrix vaccine is intended for immunization to prevent viral hepatitis A by stimulating a specific immune response based on the induction of antibodies against hepatitis A virus (HAV). In clinical studies, 99% of vaccinated people achieved seroconversion after the first dose of the vaccine.
Storage temperature 2-8 degrees
720 Junior, 1440 Adult